This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) (Learn how and when to remove this message) |
| 👁 Image | |
| Clinical data | |
|---|---|
| Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
| Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.054.221 👁 Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C16H14O5 |
| Molar mass | 286.283 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
| |
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[citation needed]
References
[edit]Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from November 2023
- All articles needing additional references
- Short description is different from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from February 2022
- All stub articles
